ClinVar Miner

Submissions for variant NM_001243133.2(NLRP3):c.1000A>G (p.Ile334Val)

dbSNP: rs1662713003
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV001202650 SCV001373772 likely pathogenic Cryopyrin associated periodic syndrome 2019-09-20 criteria provided, single submitter clinical testing This sequence change replaces isoleucine with valine at codon 336 of the NLRP3 protein (p.Ile336Val). The isoleucine residue is highly conserved and there is a small physicochemical difference between isoleucine and valine. This variant is not present in population databases (ExAC no frequency). This variant has been observed to occur as somatic mosaic in an individual affected with Muckle-Wells syndrome (PMID: 24326009) and has been observed in the germline of an individual affected with cryopyrin-associated periodic syndrome (PMID: 29047407). This variant is also known as I334V in the literature. This variant has been reported to affect NLRP3 protein function (PMID: 24326009). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.